Variant #0000985293 (NC_000006.11:g.161127501A>G, NM_000301.3:c.112A>G (PLG))
| Individual ID |
00449810 |
| Chromosome |
6 |
| Allele |
Both (homozygous) |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Affects function |
| Classification method |
ACMG |
| Clinical classification |
pathogenic (recessive) |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.161127501A>G |
| DNA change (hg38) |
g.160706469A>G |
| Published as |
K19E |
| ISCN |
- |
| DB-ID |
PLG_000017 See all 6 reported entries |
| Variant remarks |
tPA-mediated activation assays could predict the clinical outcome for Lys38Glu carriers, but fibrin-independent uPA-mediated assays could not: p.Lys38Glu variant is likely not to be able to efficiently engage fibrin, with a subsequent short half-life. Lys19 is a very conserved residue among primates. One possible mechanism for plasminogen deficiency resulting from Lys to Glu substitution could be its location in the N-terminus region. In Glu1-PLG, p.Lys38Glu variant may lead to a relaxed conformational state, which is easier to activate and degrade. |
| Reference |
Journal: Tefs 2006 Journal: Bourrienne 2020 |
| ClinVar ID |
ClinVar-RCV000014551.38 |
| dbSNP ID |
rs73015965 |
| Origin |
Germline |
| Segregation |
yes |
| Frequency |
0.00282 |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
0.00289 View details |
| Owner |
Christian Drouet |
| Database submission license |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
| Created by |
Christian Drouet |
| Date created |
2024-05-16 12:01:37 +02:00 (CEST) |
| Date last edited |
2024-05-16 12:36:23 +02:00 (CEST) |

Variant on transcripts
Screenings
|